Elastography and Treatment of Lymphoma
Launched by ASSIUT UNIVERSITY · Jul 23, 2023
Trial Information
Current as of August 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a specialized imaging technique called elastography to see how well it can help doctors assess the response of superficial lymph nodes to treatment in patients with lymphoma. Lymphoma is a type of cancer that affects the lymphatic system, which is part of the immune system. The goal is to determine if elastography can accurately show how well a patient’s lymph nodes are responding to treatment.
To be eligible for this trial, participants must have a confirmed diagnosis of lymphoma and have swollen lymph nodes that can be seen on the outside of the body. Importantly, they should not have started any treatment yet. During the trial, participants will undergo elastography tests, which are non-invasive and help visualize the lymph nodes without surgery. This study is currently not recruiting participants, but it aims to gather important information that could improve how doctors monitor lymphoma treatment in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients who are histopathologically proven as lymphoma, not receive treatment and have superficial lymphadenopathy.
- Exclusion Criteria:
- • 1-Lymphoma without superficial lymph nodes. 2-patients under treatment.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Kerols Refaat, Resident
Principal Investigator
Assiut University
Nagham Nabil, Professor
Study Director
Assiut University
Abdel-Monem Sayed, Lecture
Study Director
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported